Companies 'feel betrayed' due to capping of Covid-19 vaccine price: Shaw

She further said, "Covid Vaccine Jab Capped At Rs 250 At Private Hospitals: Government - understand vaccine cos (sic) feel betrayed as price is too low to sustain"

Kiran Mazumdar-Shaw, CMD, Biocon
Kiran Mazumdar-Shaw, CMD, Biocon
Press Trust of India New Delhi
1 min read Last Updated : Feb 28 2021 | 1:06 PM IST

Biocon Chairperson Kiran Mazumdar Shaw on Sunday hit out at the government capping COVID-19 vaccine price at Rs 250 at private hospitals, saying vaccine companies "feel betrayed" as it is too low to sustain.

Reacting to a report that the health ministry has fixed Rs 250 per shot at private hospitals and health centres, she tweeted, "We r (sic) crushing instead of incentivising vaccine industry."

She further said, "Covid Vaccine Jab Capped At Rs 250 At Private Hospitals: Government - understand vaccine cos (sic) feel betrayed as price is too low to sustain."

Mazumdar-Shaw asked, "If WHO has agreed to USD 3 per dose, why beat them down to USD 2?"

The government's capping of the vaccine price at private hospitals comes at a time when India is preparing to vaccinate people aged above 60 years and those over 45 with co-morbidities from March 1.

The COVID-19 vaccine will be given free of cost at government hospitals, while people will need to pay for it at private facilities.

It is understood that the Rs 250 ceiling per dose includes Rs 150 per dose of vaccine plus Rs 100 service charge.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :BioconKiran Mazumdar ShawCoronavirus Vaccine

First Published: Feb 28 2021 | 1:04 PM IST

Next Story